Regenicin Inc Share Price OTC Bulletin Board
Equities
US75887Q1022
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2021 | - | Sales 2022 | - | Capitalization | 491K 38.84M |
---|---|---|---|---|---|
Net income 2021 | - 0 | Net income 2022 | - 0 | EV / Sales 2021 | - |
Net Debt 2021 | 598K 47.32M | Net Debt 2022 | 627K 49.62M | EV / Sales 2022 | - |
P/E ratio 2021 |
-2
x | P/E ratio 2022 |
-0.71
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 79.1% |
Managers | Title | Age | Since |
---|---|---|---|
Randall McCoy
CEO | Chief Executive Officer | 74 | 14/07/10 |
John Weber
DFI | Director of Finance/CFO | 74 | 12/09/10 |
J. Nelson
CTO | Chief Tech/Sci/R&D Officer | 75 | 14/07/10 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Weber
DFI | Director of Finance/CFO | 74 | 12/09/10 |
Randall McCoy
CEO | Chief Executive Officer | 74 | 14/07/10 |
1st Jan change | Capi. | |
---|---|---|
+15.19% | 121B | |
+19.91% | 114B | |
+8.24% | 23.61B | |
-19.80% | 20.43B | |
-16.19% | 16.55B | |
-13.45% | 16.45B | |
-44.35% | 15.59B | |
+66.67% | 15.19B | |
+2.13% | 13.54B |